Target intelligence / Profile preview

Heparan sulfate-glucosamine 3-O-sulfotransferase 6 (HS3ST6)

Target
HS3ST6
Molecular classification
Enzyme, Sulfotransferase, Glycosyltransferase (related family)
01

Overview

Heparan sulfate-glucosamine 3-O-sulfotransferase 6 (HS3ST6) is an enzyme resident primarily in the Golgi membrane that catalyzes the transfer of sulfo groups to the 3-O position of glucosamine units in heparan sulfate chains using PAPS as the sulfo donor. This modification is rare but functionally critical, as 3-O-sulfated HS motifs mediate protein interactions involved in cell signaling, blood coagulation, and viral pathogenesis—particularly as receptors for Herpes simplex virus-1. The expression and function of HS3ST6 are implicated in hereditary angioedema, cancer, and other diseases. The HS3ST family includes seven human isoforms, each with discrete substrate specificity and biological roles. HS3ST6 does not participate in anticoagulant heparan sulfate generation, distinguishing it from family members like HS3ST1 and HS3ST5. Modulating HS3ST6 or related enzymes remains an area of active research for novel therapeutic strategies.

Other names
HS3ST63-OST-6h3-OST-6Heparan sulfate glucosamine 3-O-sulfotransferase 6Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 63OST6HAE8Heparan sulfate sulphate D-glucosaminyl 3-O-sulfotransferase-3B-like
02

Mechanism of action

Inhibition or modification of HS3ST6 may reduce 3-O-sulfation, altering heparan sulfate-protein interactions (e.g., preventing HSV-1 entry, modulating anticoagulant activity)

03

Biological functions

Heparan sulfate proteoglycan biosynthesisSulfate group transfer (3-O-sulfation)Cell surface receptor modificationModulation of cell-virus interactions (e.g., HSV-1 entry)Embryogenesis and blastocyst hatching (predicted function)
04

Disease associations

Hereditary angioedemaCancerViral infection (notably Herpes simplex virus-1)
05

Safety considerations

Modulating HS3ST6 activity can impact blood coagulation, immune responses, and susceptibility to viral infection; off-target effects and altered glycosaminoglycan signaling are potential risks
06

Biomarkers

Expression or activity of HS3ST6 may serve as a biomarker in hereditary angioedema and certain cancers characterized by abnormal heparan sulfate modification, although specific clinical biomarkers have yet to be validated

Beyond the preview

Go deeper on Heparan sulfate-glucosamine 3-O-sulfotransferase 6 (HS3ST6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heparan sulfate-glucosamine 3-O-sulfotransferase 6 (HS3ST6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call